That interpretation of the rules is being challenged in the courts by Novo Nordisk and Eli Lilly, which makes rival weight-loss therapy tirzepatide, while the compounders have countersued, claiming that the FDA's removal of the drugs from the shortages list was premature
Dose reduction, slower titration schedules, or temporary pauses allow the nervous system to acclimate
Researchers have not definitively established causation, but several factors likely contribute
Aggregated peptide fragments can trigger injection site reactions that the native peptide does not cause
Ultimately, the goal is to remove every possible variable that isn't the one you're trying to test
Risk reductions were even stronger in people with psoriasis vs